Loading...
Immunological evaluation of rheumatoid arthritis patients treated with itolizumab
Rheumatoid arthritis is an autoimmune disease characterized by joint inflammation that affects approximately 1% of the general population. Itolizumab, a monoclonal antibody specific for the human CD6 molecule mainly expressed on T lymphocytes, has been shown to inhibit proliferation of T cells and p...
Na minha lista:
Udgivet i: | MAbs |
---|---|
Main Authors: | , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Taylor & Francis
2015
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966522/ https://ncbi.nlm.nih.gov/pubmed/26466969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1105416 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|